CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that its Board of Directors has authorized the repurchase of up to $50 million of the Company’s shares of common stock.
